4.1 Article

Establishment of a Robust Platform for Induced Pluripotent Stem Cell Research Using Maholo LabDroid

Journal

SLAS TECHNOLOGY
Volume 26, Issue 5, Pages 441-453

Publisher

SAGE PUBLICATIONS INC
DOI: 10.1177/24726303211000690

Keywords

laboratory automation; induced pluripotent stem cells (iPSCs); drug discovery; automated cell culture system

Funding

  1. Japan Agency for Medical Research and Development (AMED)

Ask authors/readers for more resources

This study established a platform utilizing a humanoid robotic system to conduct iPSC experiments, successfully automating multiple processes with excellent reproducibility and flexibility. The robot system showed high accuracy and robustness, able to maintain undifferentiated iPSCs for an extended period and achieve a high differentiation rate with muscular disease patient-derived iPSCs. The expandability and flexibility of the robot system allowed for experimentation with multiple cell lines simultaneously.
Induced pluripotent stem cells (iPSCs) are attractive for use in early drug discovery because they can differentiate into any cell type. Maintenance cultures and differentiation processes for iPSCs, however, require a high level of technical expertise. To overcome this problem, technological developments such as enhanced automation are necessary to replace manual operation. In addition, a robot system with the flexibility and expandability to carry out maintenance culture and each of the required differentiation processes would also be important. In this study, we established a platform to enable the multiple processes required for iPSC experiments using the Maholo LabDroid, which is a humanoid robotic system with excellent reproducibility and flexibility. The accuracy and robustness of Maholo LabDroid enabled us to cultivate undifferentiated iPSCs for 63 days while maintaining their ability to differentiate into the three embryonic germ layers. Maholo LabDroid maintained and harvested iPSCs in six-well plates, then seeded them into 96-well plates, induced differentiation, and implemented immunocytochemistry. As a result, Maholo LabDroid was confirmed to be able to perform the processes required for myogenic differentiation of iPSCs isolated from a patient with muscular disease and achieved a high differentiation rate with a coefficient of variation (CV) <10% in the first trial. Furthermore, the expandability and flexibility of Maholo LabDroid allowed us to experiment with multiple cell lines simultaneously.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.1
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available